Loading...
Aarti Drugs Buyback Detail
Buyback Record Date April 1, 2021
Buyback Open Date April 27, 2021
Buyback Closing Date May 10, 2021
Issue Size (Shares) 0.06 Crores
Issue Size (Amount) ₹60.00 Crores
Buyback Price ₹1000 per Share
  1. Aarti Drugs jumps 4%, partly recoups last two days� losses

    Sep 13, 2023 12:26:00 PM

    The board of Aarti Drugs had in July approved a share buyback of Rs 59.85 crore, which had then sent the stock soaring. The buyback of 0.72 percent of the total equity of Aarti Dr ...

    Publish by : moneycontrol.com
  2. Aarti Drugs - Announcement under Regulation 30 (LODR)-Closure of Buy Back

    Sep 1, 2023 6:49:00 PM

    Invest in high-rated bonds from as low as Rs. 10,000 Find & Invest in bonds issued by top corporates, PSU Banks, NBFCs, and much more. Invest as low as 10,000 and earn better returns than FD ...

    Publish by : moneycontrol.com
  3. Aarti Drugs share price

    Sep 26, 2023 3:30:00 AM

    Aarti Drugs Limited is an India-based company that is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations.

    Publish by : Mint
  4. Aarti Drugs Ltd (ADRG)

    Sep 26, 2023 1:31:00 PM

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

    Publish by : Investing
  5. AARTI DRUGS (NSE:AARTIDRUGS) Price Target Increased by 9.47% to 530.74

    Aug 22, 2023 3:30:00 AM

    The average one-year price target for AARTI DRUGS (NSE:AARTIDRUGS) has been revised to 530.74 / share. This is an increase of 9.47% from the prior estimate of 484.84 dated July 5, 2023.

    Publish by : Nasdaq
  6. Aarti Drugs Adhish P Patil Speaks On The Firms Q2FY23 Results | Trading Hour | CNBC-TV18

    Sep 4, 2023 2:37:00 AM

    Aarti Drugs reported total income of Rs. 687.78 crores during the period ended September 30, 2022 as compared to Rs. 622.22 crores during the period ended June 30, 2022.The company has posted net ...

    Publish by : MSN
  7. Target EBITDA Margin In The Range Of 14.5-15% By H2FY24: Aarti Drugs | CNBC TV18

    Aug 15, 2023 6:55:00 PM

    1QWithCNBCTV18 | Target 14.5-15% EBITDA Margin by H2FY24, says Adhish Patil, CFO, Aarti Drugs. Tells @_soniashenoy, @blitzkreigm, & @ekta_batra the company is targetting volume growth of 15-20%.

    Publish by : MSN
  8. Aarti Drugs Ltd (AARTIDRUGS) Share Price

    Feb 10, 2023 6:49:00 AM

    Aarti Drugs Ltd share price was down by -2.43% from the previous closing price of ?593.35. Who are peers of Aarti Drugs Ltd? The peers of Aarti Drugs Ltd are Glenmark Pharmaceuticals Ltd ...

    Publish by : Business Today
  9. Aarti Drugs Ltd.

    Sep 25, 2023 3:30:00 AM

    Aarti Drugs which holds an expertise of working in collaboration with the government and local NGOs has carried out rehabilitation in drought affected areas of Aurangabad through Shree ...

    Publish by : NDTV
  10. Aarti Drugs Ltd (ADRG)

    Sep 20, 2023 1:29:00 PM

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

    Publish by : Investing
  11. Aarti Drugs Ltd.

    Aug 22, 2023 3:30:00 AM

    We have audited the accompanying financial statements of AARTI DRUGS LIMITED ("the Company"), which comprise the Balance sheet as at 31st March, 2016, the Statement of Profit and Loss, the Cash ...

    Publish by : NDTV

Read Aarti Drugs Buyback current news. Find Aarti Drugs Buyback subscription news, Buyback analysis, broker reviews, allotment news, and listing date. Get the Aarti Drugs Limited Buyback grey market premium and Aarti Drugs Buyback expected listing price.